Silicone breast implants, breast cancer and specific connective tissue diseases: A systematic review of the data in the epidemiological literature

International Journal of Toxicology

Volumn 17, Issue 4, 1998, Pages 497-527

  Lamm, Steven H ^a  

^a Epidemiology and Occupational Health Inc   (United States)

Author keywords

Breast cancer; Connective tissue diseases; Meta analysis; Silicone breast implants; Systematic review

Indexed keywords

ADULT; BREAST CANCER; BREAST ENDOPROSTHESIS; CASE CONTROL STUDY; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SAFETY; SILICONE PROSTHESIS; STATISTICAL ANALYSIS;

EID: 0031863403     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158198226297     Document Type: Conference Paper

References (73)

1. Berkel, H., Birdsell, D. C., and Jenkins, H. 1992. Breast augmentation: A risk factor for breast cancer? [see comments]. N. Engl. J. Med. 326:1649-1653.
2. Brinton, L. A., Malone, K. E., and Coates, R. J. et al. 1996. Breast enlargement and reduction: Results from a breast cancer case-control study. Plast. Reconstr. Surg. 97:269-275.
3. Brozena, S. J., Fenske, N. A., and Cruse, C. W. et al. 1988. Human adjuvant disease following augmentation mammoplasty. Arch. Dermatol. 124:1383-1386.
4. Bryant, H., and Brasher, P. 1995. Breast implants and breast cancer - Reanalysis of a linkage study. N. Engl. J. Med. 332:1535-1539.
5. Burns, C. G. 1994. The epidemiology of systemic sclerosis: A population-based case-control study. In Epidemiology, ed. -, 183. University of Michigan.
6. Burns, C. J., Laing, T. J., Gillespie, B. W., Heeringa, S. G., Alcser, K. H., Mayes, M. D., Wasko, M. C., Cooper, B. C., Garabrant, D. H., and Schottenfeld, D. 1996. The epidemiology of scleroderma among women: Assessment of risk from exposure to silicone and silica. J. Rheumatol. 23:1904-1911.
7. Cook, L. S., Daling, J. R., Voigt, L. F, deHart, M. P., Malone, K. E., Stanford, J. L., Weiss, N. S., Brinton, L. A., Gammon, M. D., and Brogan, D. 1997. Characteristics of women with and without breast augmentation. JAMA 277(20): 1612-1617.
8. Deapen, D. M., Pike, M. C., Casagrande, J. T, and Brody, G. S. 1986. The relationship between breast cancer and augmentation mammaplasty: An epidemiologic study. Plast. Reconstr. Surg. 77:361-368.
9. Deapen, D. M., and Brody, G. S. 1992. Augmentation mammaplasty and breast cancer: A 5-year update of the Los Angeles study. Plast. Reconstr. Surg. 89:660-665.
10. Deapen, D. M., and Brody, G. S. 1995. Augmentation mammaplasty and breast cancer: A 5-year update of the Los Angeles study J. Clin. Epidemiol. 48:551-556.
11. Deapen, D. M., Bernstein, L., and Brody, G. S. 1997. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles study Plast. Reconstr. Surg. 99:1346-1353.
12. Dreyfuss, D. A., Singh, S., Dowlatshahi, K, and Krizek, T. J. 1987. Silicone implants as an anticarcinogen. Surg. Forum 38:587.
13. Dugowson, C. E., Daling, J., Koepsell, T. D., Voigt, L., and Nelson, J. L. 1992. Silicone breast implants and risk for rheumatoid arthritis. Arth. Rheum. 35:S66.
14. Endo, L. P., Edwards, N. L., Longley, S., Corman, L. C., and Panush, R. S. 1987. Silicone and rheumatic diseases. Semin. Arth. Rheum. 17:112-118.
15. Edworthy, S. M., Martin, L., Barr, S. G, Birdsell, D. C., Brant, R. F., and Fritzler, M. J. 1998. A clinical study of the relationship between silicone breast implants and connective tissue disease. The Journal of Rheumatology 25(2):254-260.
16. Engel, A., and Lamm, S. H. 1992. Risks of sarcomas of the breast among women with breast augmentation [letter]. Plast. Reconstr. Surg. 89:571-572.
17. Engel, A., Lamm, S. H., and Lai, S. H. 1995. Human breast sarcoma and human breast implantation: A time trend analysis based on SEER data (1973-1990). J. Clin. Epidemiol. 48:539-544.
18. Englert, H. J., and Brooks, P. 1994. Scleroderma and augmentation mammoplasty - A causal relationship? Aust. N. Z. J. Med. 24:74-80.
19. Englert, H. J., Howe, G. B., Penny, R., and Brooks, P. 1994. Scleroderma and silicone breast implants. Br. J. Rheumatol. 33:397-399.
20. Englert, H., Morris, D., and March, L. 1996. Scleroderma and silicone gel breast prostheses - the Sydney study revisited. Australian and New Zealand Journal of Medicine 26:349-355.
21. Fock, K. M., Feng, P. H., and Tey, B. H. 1984. Autoimmune disease developing after augmentation mammoplasty: Report of three cases. J. Rheumatol. 11:98-100.
22. Friis, S., McLaughlin, J. K., and Kuehn, P. G. 1997. Carcinogenic potential of silicone breast implants and cancer risk in Denmark. Int. J. Cancer 71:956-958.
23. Friis, S., Mellemkjaer, L., McLaughlin, J. K., Breiting, V, Kjaer, S. K., Blot, W., and Olsen, J. H. 1997. Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Annals of Plastic Surgery 39:1-8.
24. Gabriel, S. E., O'Fallon, W. M., Kurland, L. T., Beard, C. M., Woods, J. E., and Melton, L. J. 1994. Risk of connective-tissue diseases and other disorders after breast implantation [see comments]. N. Engl. J. Med. 330:1697-1702.
25. Garrido, L., Bogdanova, A. Y., Pfleiderer, B., and Brady, T. J. 1994. Degradation and bioactivity of implanted silicones (Abstract). In Proceedings of the Second Annual Meeting of the Society of Magnetic Resonance. p. 1468.
26. Giltay, E. J., Bernelot Moens, H. J., Riley, A. H., and Tan, R. G. 1994. Silicone breast prostheses and rheumatic symptoms: A retrospective follow up study. Ann. Rheum. Dis. 53:194-196.
27. Glasser, J. W., Lee, N. C., and Wingo, P. A. 1989. Does breast augmentation increase the risk of breast cancer? Epidemic Intelligence Service. April 3-7, 43.
28. Goldman, J. A., Greenblatt, J., Joines, R., White, L., Aylward, B., and Lamm, S. H. 1995. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J. Clin. Epidemiol. 48:571-582.
29. Guillaume, J. C., Roujeau, J. C., and Touraine, R. 1984. Systemic lupus after breast prosthesis. Ann. Dermatol. Venereol. 111:703-704.
30. Gutierrez, F. J., and Espinoza, L. R. 1990. Progressive systemic sclerosis complicated by severe hypertension: Reversal after silicone implant removal. Am. J. Med. 89:390-392.
31. Habal, M. B. 1979. Current status of biomaterial's clinical applications in plastic and reconstructive surgery. Biomater. Med. Devices Artif. Organs 7:229-741.
32. Haga, H. J., Haaland, P., and Haga, T. 1992. Silicone breast implants and collagen diseases. Tidsskr Nor Laegeforen. 112:763-764.
33. Hammer, M., and Krippner, H. 1991. Three cases of chronic polyarthritis after silicon implantation (breast augmentation): Causal relationship? Immun. Infekt. 19:62-63.
34. Hennekens, C. H., Lee, I. M., and Cook, N. R. et al. 1996. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA 275:616-621.
35. Hochberg, M. C. 1993. Cosmetic surgical procedures and connective tissue disease: The Cleopatra syndrome revisited. (Editorial; comment) (See comments). Ann. Intern. Med. 118:981-983.
36. Hochberg, M. C., White, B., Steen, V., Medsger, T. A., Weisman, M., and Wigley, F. M., 1993. The association of augmentation mammoplasty with systemic sclerosis: Preliminary results from a case-control study (abstract). Arth. Rheum. 36:S71.
37. Hochberg, M. C., Perlmutter, D. L., and White, B. et al. 1994. The association of augmentation mammoplasty with systemic sclerosis: Results from a multicenter case-control study (abstract). Arth. Rheum. 37:S369.
38. Hochberg, M. C., and Perlmutter, D. L. 1996. The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): A meta-analysis. Curr. Top. Microbiol. Immunol. 210: 411-417.
39. Hochberg, M. C., Perlmutter, D. L., and Medsger, T. A. J. et al. 1996. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arth. Rheum. 39:1125-1131.
40. Kaiser, W., and Zazgornik, J. 1992. Does silicone induce autoimmune diseases? Review of the literature and case reports. J. Rheumatol. 51:31-34.
41. Kern, K. A., Flannery, J. T., and Kuehn, P. G. 1997. Carcinogenic potential of silicone breast implants: A Connecticut statewide study. Plast. Reconstr. Surg. 100:737-749.
42. Kessler, D. A. 1992. Special Report: The basis of the FDA's decision on breast implants. New Engl. J. Med. 326:1713-1715.
43. Kumagai, Y., Abe, C., and Shiokawa, Y. 1979. Scleroderma after cosmetic surgery: Four cases of human adjuvant disease. Arth. Rheum. 22:532-537.
44. Kurland, L. T., and Homburger, H. A. 1996. Epidemiology of autoimmune and immunological diseases in association with silicone implants: Is there an excess of clinical disease or antibody response in population-based or other controlled studies? Curr. Top. Microbiol. Immunol. 210:427-430.
45. Lacey, J. V. Jr., Laing, T. J., Gillespie, B. W., and Schottenfeld, D. 1997. Reply re: Epidemiology of scleroderma among women: Assessment of risk from exposure to silicone and silica. Journal of Rheumatology 24:1853-1855.
46. Laing, T. J., Gillespie, B. W., Lacey, J. V., Jr., Garabrant, D. H., Cooper, B. C., Heeringa, S. G, Alcser, K H., Cho, S., Mayes, M. D., and Schottenfeld, D. 1996. The association between silicone exposure and undifferentiated connective tissue disease among women in Michigan and Ohio. Arthritis & Rheumatism 39:S150.
47. Lamm, S. H., and Engel, A. 1989. Human breast sarcoma incidence and silicone breast implantation rates: A comparison. J. Clin. Res. Drug Dev. 3:218-219.
48. Malone, K. E., Stanford, J. L., Daling, J. R., and Voigt, L. F. 1992. Implants and breast cancer (letter). Lancet 339:1365.
49. Mantel, N., and Haenszel, W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J. Nat. Cancer Inst. 22:719-748.
50. Marik, P. E., Kark, A. L., and Zambakides, A. 1990. Scleroderma after silicone augmentation mammoplasty. A report of two cases. S. Afr. Med. J. 77:212-213.
51. May, D. S., and Stroup, N. E. 1991. The incidence of sarcomas of the breast among women in the United States, 1973-1986 (letter). Plast. Reconstr. Surg. 87:193-194.
52. McLaughlin, J. K., Fraumeni, J. F., Jr., Olsen, J. H., and Mellmkjaer, L. 1994. Re: Breast implants, cancer, and systemic sclerosis. J. Natl. Cancer. Inst. 86:1424.
53. McLaughlin, J. K., Fraumeni, J. F., Jr., Nyren, O., and Adami, H. O. 1995. Silicone breast implants and risk of cancer? (letter). JAMA 273:116.
54. McLaughlin, J. K, Olsen, J. H., Friis, S., Mellemkjaer, L., and Fraumeni, J. F., Jr. 1995. Re: Breast implants, cancer, and systemic sclerosis (letter). J. Natl. Cancer Inst. 87:1415-1416.
55. McLaughlin, J. K., Nyren, O., Blot, W. J., Yin, L., Josefsson, S., Fraumeni, J. F., and Adami, H. O. 1998. Cancer risk among women with cosmetic breast implants: a population-based cohort study in Sweden. J. Natl. Cancer Inst. 90:156-158.
56. Morgan, R. W., and Elcock, M. 1995. Artificial implants and soft tissue sarcomas. J. Clin. Epidemiol. 48:545-549.
57. Nyrén, O., Yin, L., Josefsson, S., McLaughlin, J. K., Blot, W. J., Engqvist, M., Hakelius, L., Boice, J. D., Jr., and Adami H.-O. 1988. Risk of connective tissue disease and related disorders among women with breast implants: A nation-wide retrospective cohort study in Sweden. British Medical Journal 316(7129):417-421.
58. Okano, Y., Nishikai, M., and Sato, A. 1984. Scleroderma, primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: A case report of possible human adjuvant disease. Ann. Rheum. Dis. 43:520-522.
59. Park, A. J., Black, R. J., Sarhadi, N. S., Chetty, U., and Watson, A. C. H. 1998. Silicone gel-filled breast implants and connective tissue diseases. Plastic and Reconstructive Surg. 101(2):261-268.
60. Perkins, L. L., Clark, B. D., Klein, P. J., and Cook, R. R. 1995. A meta-analysis of breast implants and connective tissue disease. Ann. Plast. Surg. 35:561-570.
61. Petit, J. Y, Le, M. G., Mouriesse, H., Rietjens, M., Gill, P., Contesso, G., and Lehman, A. 1994. Can breast reconstruction with gel-filled silicone implants increase the risk of death and second primary cancer in patients treated by mastectomy for breast cancer? Plast. Reconstr. Surg. 94:115-119.
62. Pope, A. 1733. Essay on man, epistle two.
63. Ramasastry, S. S., Weinstein, L. W., Zerbe, A., Narayanan, K, LaPietra, D., and Futrell, J. W 1991. Regression of local and distant tumor growth by tissue expansion: An experimental study of mammary carcinoma 13762 in rats. Plast. Reconstr. Surg. 87:1.
64. Sanchez-Guerrero, J., Colditz, G. A., Karlson, E. W., Hunter, D. J., Speizer, F. E., and Liang, M. H. 1995. Silicone breast implants and the risk of connective-tissue diseases and symptoms (See comments). N. Engl. J. Med. 332:1666-1670.
65. Spiera, H. 1988. Scleroderma after silicone augmentation mammoplasty. JAMA 260:236-238.
66. Strom, B. L., Reidenberg, M. M., Freundlich, B., and Schinnar, R. 1994. Breasts silicon implants and risk of systemic lupus erythematosus. J. Clin. Epidemiol. 47:1211-1214.
67. Su, C. W., Dreyfuss, D. A., Krizek, T. J., and Leoni, K. J. 1995. Silicone implants and the inhibition of cancer. Plast. Reconstr. Surg. 96:513-520.
68. van Nunen, S., Gatenby, P. A., and Basten, A. 1982. Post-mammoplasty connective tissue disease. Arth. Rheum. 25:694-697.
69. Varga, J., Schumacher, H. R., and Jimenez, S. A. 1989. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann. Intern. Med. 111:377-383.
70. Weisman, M. H., Vecchione, T. R., Albert, D., Moore, L. T., and Mueller, M. R. 1988. Connective-tissue disease following breast augmentation: A preliminary test of the human adjuvant disease hypothesis. Plast. Reconstr. Surg. 82:626-630.
71. Wells, K. E., Cruse, C. W., Baker, J. L., Jr., Daniels, S. M., Stern, R. A., Newman, C., Scleznick, M. J., Vasey, F. B., Brozena, S., Albers, S. E., and Frenske, N. 1994. The health status of women following cosmetic surgery. Plast. Reconstr. Surg. 93:907-912.
72. Wolfe, F. 1995. Silicone breast implants and the risk of fibromyalgia and rheumatoid arthritis. Arth. Rheum. 38:S265.
73. Wong, O. 1996. A critical assessment of the relationship between silicone breast implants and connective tissue diseases. Regul. Toxicol. Pharmacol. 23(1 Pt 1): 74-85.